Related Experiment Video
Updated: Dec 20, 2025
09:20
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
Published on: July 3, 2025
1.0K
Treatment for Mycobacterium avium complex lung disease
Sheng-Wei Pan1, Chin-Chung Shu2, Jia-Yih Feng3
1Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Institute of Public Health, National Yang-Ming University, Taipei, Taiwan.
Summary
Mycobacterium avium complex lung disease (MAC-LD) treatment is challenging due to antibiotic intolerance and adherence issues. Guideline-based therapy with macrolide, rifamycin, and ethambutol is crucial for successful outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Mycobacterium avium complex (MAC) is a leading cause of nontuberculous mycobacteria lung disease (MAC-LD) globally.
- Increasing MAC-LD burden is complicated by treatment challenges including antibiotic intolerance, poor adherence, and recurrence.
- Current treatment strategies are often based on limited evidence from observational studies or small trials.
Purpose of the Study:
- To review and emphasize current guideline-based treatment recommendations for MAC-LD.
- To highlight the importance of adherence to standard antibiotic regimens for achieving successful treatment outcomes.
- To underscore the challenges and critical factors influencing MAC-LD management.
Main Methods:
- Review of current clinical guidelines for MAC-LD treatment.
- Analysis of factors affecting treatment success and failure, including adherence and resistance.
- Emphasis on standard three-drug antibiotic regimens and monitoring.
Main Results:
- Guideline-based antibiotic therapy is recommended for severe MAC-LD, cavitary lesions, or disease progression.
- A standard regimen includes macrolide, rifamycin, and ethambutol, continued for 12 months post-sputum conversion.
- Treatment success is achieved in approximately two-thirds of treatment-naïve patients adhering to guidelines and without macrolide resistance.
Conclusions:
- Adherence to guideline-based therapy is paramount for successful MAC-LD treatment.
- Macrolide resistance significantly worsens patient outcomes.
- While new treatments are needed, optimizing current guideline adherence is the most critical factor in managing MAC-LD.
Related Concept Videos
01:28Pulmonary Tuberculosis V
465
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
465
01:26Pulmonary Tuberculosis IV
423
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
423
01:29Pulmonary Tuberculosis I
741
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
741
01:31Pulmonary Tuberculosis III
795
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
795
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
01:28Pneumonia IV: Management
664
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
664